EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 4 (Avril 2010) Med Sci (Paris), 26 4 (2010) 371-376 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 4, Avril 2010
Page(s) 371 - 376
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010264371
Published online 15 April 2010
  1. Pinter JD, Eliez S, Schmitt JE, et al. Neuroanatomy of Down’s syndrome: a high-resolution MRI study. Am J Psychiatry 2001; 158 : 1659–65. [Google Scholar]
  2. Mann DM, Royston MC, Ravindra CR. Some morphometric observations on the brains of patients with Down’s syndrome: their relationship to age and dementia. J Neurol Sci 1990; 99 : 153–64. [Google Scholar]
  3. Delabar JM, Theophile D, Rahmani Z, et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1993; 1 : 114–24. [Google Scholar]
  4. Ronan A, Fagan K, Christie L, et al. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region. Med Genet 2007; 44 : 448–51. [Google Scholar]
  5. Aït Yahya-Graison E, Aubert J, Dauphinot L, et al. Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. Am J Hum Genet 2007; 81 : 475–91. [Google Scholar]
  6. Kleschevnikov AM, Belichenko PV, Villar AJ, et al. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 2004; 24 : 8153–60. [Google Scholar]
  7. Shinohara T, Tomizuka K, Miyabara S, et al. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down’s syndrome. Hum Mol Genet 2001; 10 : 1163–75. [Google Scholar]
  8. O’Doherty A, Ruf S, Mulligan C, et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 2005; 309 : 2033–7. [Google Scholar]
  9. Ortiz-Abalia J, Sahún I, Altafaj X, et al. Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome. Am J Hum Genet 2008; 83 : 479–88. [Google Scholar]
  10. Lee EB, Leng LZ, Zhang B, et al. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. J Biol Chem 2006; 281 : 4292–9. [Google Scholar]
  11. Roper RJ, VanHorn JF, Cain CC, Reeves RH. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev 2009; 126 : 212–9. [Google Scholar]
  12. Clark S, Schwalbe J, Stasko MR, et al. Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome. Exp Neurol 2006; 200 : 256–61. [Google Scholar]
  13. Fernandez F, Morishita W, Zuniga E, et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 2007; 10 : 411–3. [Google Scholar]
  14. Rueda N, Flórez J, Martínez-Cué C. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Neurosci Lett 2008; 433 : 22–7. [Google Scholar]
  15. Salehi A, Faizi M, Colas D, et al. Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome. Sci Transl Med 2009; 7 : 7–17. [Google Scholar]
  16. Costa AC, Scott-McKean JJ, Stasko MR. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Neuropsychopharmacology 2008; 33 : 1624–32. [Google Scholar]
  17. Dowjat WK, Adayev T, Kuchna I, et al. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett 2007; 413 : 77–81. [Google Scholar]
  18. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003; 371 : 199–204. [Google Scholar]
  19. Guedj F, Sébrié C, Rivals I, et al. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLOS One 2009; 4 : e4606. [Google Scholar]
  20. Turleau C, Vekemans M. Trisomie 21 : 50 ans entre médecine et science. Med Sci (Paris) 2010; 26 : 267–72. [Google Scholar]
  21. Langui D, Lachapelle F, Duyckaerts C. Modèles animaux des maladies neurodégénératives. Med Sci (Paris) 2007; 23 : 180–6. [Google Scholar]
  22. Clavaguera F, Goedert M, Tolnay M. Induction et propagation de la pathologie par la protéine tau chez un modèle murin de la maladie d’Alzheimer. Med Sci (Paris) 2010; 26 : 121–5. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.